Showing results (661-670 of 944) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|October 22, 2024
The Association Between Constipation and Positron Emission Tomography and Blood-Based Biomarkers in Older Cognitively Unimpaired Adults with Higher Amyloid-β BurdenHeling Chu, Chuyi Huang, Fang Xie, et al.
Neurology and Therapy|September 17, 2024
Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying TherapiesSamuel P Dickson, Craig H Mallinckrodt, Basia Rogula, et al.
Neurology and Therapy|May 11, 2025
Advancing Future Amyotrophic Lateral Sclerosis Medicines by Incorporating The Patient Voice Into Patient-Centered Holistic Measurement Strategies for Clinical and Real-World Studies: Results from Targeted Literature ReviewsDiana Rofail, Michael Chladek, Betsy Williams, et al.
Neurology and Therapy|May 15, 2025
What Patients Don't Say and Physicians Don't Ask: A Needs Assessment in Myasthenia Gravis Integrating Patient and Healthcare Professional PerspectivesCornelia Reyes Acosta, Ivo Vlaev, Alexis Rodriguez, et al.
Neurology and Therapy|May 4, 2025
Characterizing the Journey of Early Alzheimer's Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence StudyMarwan N Sabbagh, Chenyue Zhao, Malena Mahendran, et al.
Neurology and Therapy|May 3, 2025
Incidence and Prevalence of Juvenile Myasthenia Gravis in the United States Between 2010 and 2020: Analysis of Two Claims DatabasesJiachen Zhou, Anna Kuba, Sigrid Nilius, et al.
Neurology and Therapy|April 7, 2025
The Cognivue Amyloid Risk Measure (CARM): A Novel Method to Predict the Presence of Amyloid with Cognivue ClarityJames E Galvin, Michael J Kleiman, Heather M Harris, et al.
Neurology and Therapy|March 14, 2025
Menopause, Perimenopause, and Migraine: Understanding the Intersections and Implications for TreatmentMarta Waliszewska-Prosół, Giovanni Grandi, Raffaele Ornello, et al.
Neurology and Therapy|March 12, 2025
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk StudySimona Lattanzi, Laura Canafoglia, Maria Paola Canevini, et al.
Neurology and Therapy|March 24, 2025
Long-Term Management and Therapeutic Sequencing for Patients with Relapsing Multiple Sclerosis in France: A Vignette StudyPatrick Vermersch, Xavier Moisset, Baptiste Roux, et al.
Pageof 95